Pathologie du tube digestif < Pathologie expérimentale < Pathologie neuromusculaire

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 49.
[0-20] [0 - 20][0 - 49][20-40]

Ident.	Authors (with country if any)	Title
000599 (2007)	Penelope J. Hallett [États-Unis] ; J. M. Brotchie [Canada]	Striatal delta opioid receptor binding in experimental models of Parkinson's disease and dyskinesia
000793 (2005)	Bianca Marchetti [Italie] ; Pier Andrea Serra [Italie] ; Cataldo Tirolo [Italie] ; Francesca L'Episcopo [Italie] ; Salvo Caniglia [Italie] ; Florinda Gennuso [Italie] ; Nuccio Testa [Italie] ; Egidio Miele [Italie] ; Speranza Desole [Italie] ; Nicholas Barden [Canada] ; Maria Concetta Morale [Italie]	Glucocorticoid receptor-nitric oxide crosstalk and vulnerability to experimental parkinsonism : pivotal role for glia-neuron interactions
000988 (2002)	J. Q. Lu [Canada] ; A. J. Stoessl [Canada]	Somatostatin modulates the behavioral effects of dopamine receptor activation in parkinsonian rats
000B94 (2000)	C. S. Lee [Canada] ; M. A. Cenci [Suède] ; M. Schulzer [Canada] ; A. Björklund [Suède]	Embryonic ventral mesencephalic grafts improve levodopa-induced dyskinesia in a rat model of Parkinson's disease
000C23 (1999)	M. C. Evans [États-Unis] ; A. Pradhan [Canada] ; S. Venkatraman [États-Unis] ; W. H. Ojala [États-Unis] ; W. B. Gleason [États-Unis] ; R. K. Mishra [Canada] ; R. L. Johnson [États-Unis]	Synthesis and dopamine receptor modulating activity of novel peptidomimetics of L-prolyl-L-leucyl-glycinamide featuring α, α-disubstituted amino acids
000C56 (1999)	T. Inoue [Canada, Japon] ; J. Tsui [Canada] ; N. Wong [Canada] ; SHIN YI WONG [Canada] ; F. Suzuki [Japon] ; YIN NAM KWOK [Canada]	Expression of glial cell line-derived neurotrophic factor and its mRNA in the nigrostriatal pathway following MPTP treatment
000C64 (1999)	E. M. Khalil [États-Unis] ; W. H. Ojala [États-Unis] ; A. Pradhan [Canada] ; V. D. Nair [Canada] ; W. B. Gleason [États-Unis] ; R. K. Mishra [Canada] ; R. L. Johnson [États-Unis]	Design, synthesis, and dopamine receptor modulating activity of spiro bicyclic peptidomimetics of L-prolyl-L-leucyl-glycinamide
000C69 (1999)	F. Calon [Canada] ; M. Morissette [Canada] ; M. Goulet [Canada] ; R. Grondin [Canada] ; P. J. Blanchet [Canada] ; P. J. Bedard [Canada] ; T. Di Paolo [Canada]	Chronic D1 and D2 dopaminomimetic treatment of MPTP-denervated monkeys : effects on basal ganglia GABAA/ benzodiazepine receptor complex and GABA content
000D78 (1997)	N. A. Tatton [Canada] ; S. J. Kish [Canada]	In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and Acridine Orange Staining
000D93 (1997)	P. W. Baures [États-Unis] ; W. H. Ojala [États-Unis] ; W. J. Costain [Canada] ; M. C. Ott [Canada] ; A. Pradhan [Canada] ; W. B. Gleason [États-Unis] ; R. K. Mishra [Canada] ; R. L. Johnson [États-Unis]	Design, synthesis, and dopamine receptor modulating activity of diketopiperazine peptidomimetics of L-prolyl-L-leucylglycinamide
000E26 (1996)	E. I. Miklyaeva [Canada] ; I. Q. Whishaw [Canada]	HemiParkinson analogue rats display active support in good limbs versus passive support in bad limbs on a skilled reaching task of variable height
000E28 (1996)	M. Goulet [Canada] ; R. Grondin ; P. J. Blanchet ; P. J. Bedard ; T. Di Paolo [Canada]	Dyskinesias and tolerance induced by chronic treatment with a D1 agonist administered in pulsatile or continuous mode to not correlate with changes of putaminal D1 receptors in drug-naive MPTP monkeys
000E29 (1996)	P. J. Blanchet [Canada] ; R. Grondin ; P. J. Bedard	Dyskinesia and wearing-off following dopamine D1 agonist treatment in drug-naive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned primates
000E36 (1996)	R. Grondin [Canada] ; M. Goulet [Canada] ; T. Di Paolo [Canada] ; P. J. Bedard [Canada]	Cabergoline, a long-acting dopamine D2-like receptor agonist, produces a sustained antiparkinsonian effect with transient dyskinesias in parkinsonian drug-naive primates
000F10 (1994)	P. J. Blanchet [Canada] ; R. Boucher [Canada] ; P. J. Bedard	Excitotoxic lateral pallidotomy does not relieve L-DOPA-induced dyskinesia in MPTP parkinsonian monkeys
000F36 (1993)	M. Takada [Canada] ; T. Sugimoto ; T. Hattori [Canada]	MPTP neurotoxicity to cerebellar Purkinje cells in mice
000F44 (1993)	B. Gomez-Mancilla [Canada] ; R. Boucher ; C. Gagnon ; T. Di Paolo ; R. Markstein ; P. J. Bedard	Effect of adding the D1 agonist CY 208-243 to chronic bromocriptine treatment. I: Evaluation of motor parameters in relation to striatal catecholamine content and dopamine receptors
000F46 (1993)	B. D. Pate [Canada] ; T. Kawamata ; T. Yamada ; E. G. Mcgeer [Canada] ; K. A. Hewitt [Canada] ; B. J. Snow [Canada] ; T. J. Ruth [Canada] ; D. B. Calne [Canada]	Correlation of striatal fluorodopa uptake in the MPTP monkey with dopaminergic indices
000F50 (1993)	C. Gagnon [Canada] ; B. Gomez-Mancilla ; P. J. Bedard ; T. Di Paolo [Canada]	Chronic CY 208-243 treatment of MPTP-monkeys causes regional changes of dopamine and GABAA receptors
000F79 (1992)	A. Tabatabaei [Canada] ; T. L. Perry ; S. Hansen ; C. Krieger	Partial protective effect of MK-4801 on MPTP-induced reduction of striatal dopamine in mice
000F89 (1992)	B. Gomez-Mancilla [Canada] ; J.-F. Latulippe ; R. Boucher ; P. J. Bedard	Effect of ethosuximide on rest tremor in the MPTP monkey model

---

List of associated Author.i

Nombre de documents	Descripteur
18	P. J. Bedard
10	T. Di Paolo
9	R. Boucher
6	B. Gomez-Mancilla
5	D. B. Calne
4	P. J. Blanchet
4	R. Grondin
3	A. Pradhan
3	C. Gagnon
3	F. B. Jolicoeur
3	L. Tremblay
3	M. Filion
3	M. Goulet
3	M. Guttman
3	R. K. Mishra
3	R. L. Johnson
3	R. Rivest
3	S. Hansen
3	T. L. Perry
3	W. B. Gleason
3	W. H. Ojala
2	A. Drumheller
2	B. D. Pate
2	H. A. Robertson
2	P. Falardeau
2	S. U. Kim
1	A. Björklund
1	A. J. Biro
1	A. J. Stoessl
1	A. Jakubovic
1	A. M. Graybiel
1	A. Tabatabaei
1	B. J. Snow
1	Bianca Marchetti
1	C. Bergeron
1	C. E. Greenwood
1	C. Krieger
1	C. Rouillard
1	C. S. Lee
1	Cataldo Tirolo
1	D. G. Herrera
1	D. H. Shin
1	D. Pare
1	E. C. Wolters
1	E. G. Mcgeer
1	E. I. Miklyaeva
1	E. M. Khalil
1	E. Mak
1	Egidio Miele
1	F. Calon
1	F. Suzuki
1	Florinda Gennuso
1	Francesca L'Episcopo
1	G. S. Robertson
1	H. C. Fibiger
1	H. Kamo
1	I. Q. Whishaw
1	I. Turnbull
1	J. C. Kebabian
1	J. D. Grimes
1	J. H. Thakar
1	J. M. Brotchie
1	J. Q. Lu
1	J. Tsui
1	J.-C. David
1	J.-F. Latulippe
1	K. A. Hewitt
1	K. Jones
1	K. Watabe
1	M. A. Cenci
1	M. C. Evans
1	M. C. Ott
1	M. Daigle
1	M. Dragunow
1	M. J. Zigmond
1	M. L. Paul
1	M. Morissette
1	M. N. Hassan
1	M. Pisa
1	M. Schulzer
1	M. Steriade
1	M. Takada
1	Maria Concetta Morale
1	N. A. Tatton
1	N. Wong
1	Nicholas Barden
1	Nuccio Testa
1	P. Bedard
1	P. L. Mcgeer
1	P. W. Baures
1	Penelope J. Hallett
1	Pier Andrea Serra
1	R. Curro'Dossi
1	R. Markstein
1	R. W. W. Tomlinson
1	S. Bouchard
1	S. J. Kish
1	S. St-Pierre
1	S. St.-Pierre
1	S. Venkatraman

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PascalFrancis/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/FC03.fr.i -k "Pathologie expérimentale" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/FC03.fr.i  \
                -Sk "Pathologie expérimentale" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    PascalFrancis
   |étape=   Checkpoint
   |type=    indexItem
   |index=    FC03.fr.i
   |clé=    Pathologie expérimentale
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022